{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:25:26Z","timestamp":1770740726009,"version":"3.49.0"},"reference-count":179,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.survophthal.2016.01.001","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T17:53:21Z","timestamp":1452794001000},"page":"400-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["New developments in giant cell arteritis"],"prefix":"10.1016","volume":"61","author":[{"given":"Larry","family":"Frohman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron B.C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaliopy","family":"Matheos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis G.","family":"Leon-Alvarado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen V.","family":"Danesh-Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2016.01.001_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.7326\/0003-4819-120-12-199406150-00003","article-title":"How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis?","volume":"120","author":"Achkar","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib2","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1742-1241.2012.02981.x","article-title":"Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series","volume":"66","author":"Adizie","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.survophthal.2016.01.001_bib3","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s10067-006-0375-2","article-title":"Treatment of refractory temporal arteritis with adalimumab","volume":"26","author":"Ahmed","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib4","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1001\/archopht.1976.03910040732006","article-title":"Skip areas in temporal arteritis","volume":"94","author":"Albert","year":"1976","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib5","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/ard.2004.025320","article-title":"Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction","volume":"64","author":"Alvarez-Lafuente","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2016.01.001_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2796.1990.tb00177.x","article-title":"Osteoporosis after long-term corticosteroid treatment of giant cell arteritis","volume":"227","author":"Andersson","year":"1990","journal-title":"J Intern Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2474-11-44","article-title":"The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis","volume":"11","author":"Arida","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.survophthal.2016.01.001_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00002281-200101000-00007","article-title":"Magnetic resonance imaging of large vessel vasculitis","volume":"13","author":"Atalay","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2174\/138161282004140213144840","article-title":"Targeting Platelet-Neutrophil Interactions in Giant-Cell Arteritis","volume":"20","author":"Baldini","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.survophthal.2016.01.001_bib10","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/bjs.7252","article-title":"Role of ultrasonography in the diagnosis of temporal arteritis","volume":"97","author":"Ball","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.survophthal.2016.01.001_bib11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10067-007-0831-7","article-title":"A case of atypical giant cell arteritis diagnosed by positron emission tomography (PET)","volume":"27","author":"Belloli","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib12","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/ard.2010.149351","article-title":"Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis","volume":"70","author":"Beyer","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2016.01.001_bib13","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/ard.2005.036533","article-title":"Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis","volume":"64","author":"Bhatia","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2016.01.001_bib14","series-title":"Histopathology of primary vasculitic disorders. Inflammatory Diseases of Blood Vessels","author":"Bj\u00f6rnsson","year":"2002"},{"key":"10.1016\/j.survophthal.2016.01.001_bib15","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3174\/ajnr.A0638","article-title":"Diagnostic value of high-resolution MR imaging in giant cell arteritis","volume":"28","author":"Bley","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/rheumatology\/kem283","article-title":"Mural inflammatory hyperenhancement in MRI of giant cell (temporal) arteritis resolves under corticosteroid treatment","volume":"47","author":"Bley","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.survophthal.2016.01.001_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/art.21699","article-title":"Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: A prospective study of 35 patients","volume":"55","author":"Blockmans","year":"2006","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.survophthal.2016.01.001_bib18","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/rheumatology\/kel376","article-title":"Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients","volume":"46","author":"Blockmans","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.survophthal.2016.01.001_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.bor.0000197996.04709.4e","article-title":"Large-vessel involvement in giant cell arteritis","volume":"18","author":"Bongartz","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib20","doi-asserted-by":"crossref","first-page":"A544","DOI":"10.1016\/j.autrev.2012.01.003","article-title":"Giant cell arteritis: A review of classification, pathophysiology, geoepidemiology and treatment","volume":"11","author":"Borchers","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.survophthal.2016.01.001_bib21","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1007\/s00296-012-2425-1","article-title":"Fever of unknown origin: large vessel vasculitis diagnosed by PET\/CT","volume":"33","author":"Bosnic","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.survophthal.2016.01.001_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9394(99)00101-4","article-title":"Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis","volume":"128","author":"Boyev","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F","article-title":"Disease pattern in cranial and large-vessel giant cell arteritis","volume":"42","author":"Brack","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib24","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1172\/JCI119477","article-title":"Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras","volume":"99","author":"Brack","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.survophthal.2016.01.001_bib25","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3899\/jrheum.080792","article-title":"Rate of discordant findings in bilateral temporal artery biopsy to diagnose giant cell arteritis","volume":"36","author":"Breuer","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib26","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/jclinpath-2012-200870","article-title":"Does preoperative steroid treatment affect the histology in giant cell (cranial) arteritis?","volume":"65","author":"Bury","year":"2012","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib27","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1002\/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO;2-Y","article-title":"Treatment of longstanding active giant cell arteritis with infliximab: report of four cases","volume":"44","author":"Cantini","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib28","first-page":"294","volume":"Vol. 33","author":"Cantini","year":"2004"},{"key":"10.1016\/j.survophthal.2016.01.001_bib29","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1212\/WNL.38.5.685","article-title":"Peripheral neuropathic syndromes in giant cell (temporal) arteritis","volume":"38","author":"Caselli","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.survophthal.2016.01.001_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/RHU.0b013e31824a48bc","article-title":"18 Fdg Pet\/Ct Contribution in Occult Giant-Cell Arteritis","volume":"18","author":"Chaigne","year":"2012","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib31","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jocn.2009.05.002","article-title":"Giant cell arteritis","volume":"16","author":"Chew","year":"2009","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.survophthal.2016.01.001_bib32","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica: a 10-year epidemiologic and clinical study","volume":"97","author":"Chuang","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1529-0131(200001)43:1<184::AID-ANR23>3.0.CO;2-N","article-title":"Cell adhesion molecules in the development of inflammatory infiltrates in giant cell arteritis - Inflammation-induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions","volume":"43","author":"Cid","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jmv.21092","article-title":"Infection and temporal arteritis: A PCR-based study to detect pathogens in temporal artery biopsy specimens","volume":"80","author":"Cooper","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib35","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/ard.2006.051979","article-title":"Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis","volume":"65","author":"Cutolo","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2016.01.001_bib36","first-page":"549","article-title":"Fever of unknown origin as initial manifestation of large vessel giant cell arteritis: diagnosis by colour-coded sonography and 18-FDG-PET","volume":"28","author":"Czihal","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib37","first-page":"2140","article-title":"Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association","volume":"25","author":"Dababneh","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ajo.2012.05.014","article-title":"Temporal Artery Biopsy: Skip It at Your Patient's Peril","volume":"154","author":"Danesh-Meyer","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00041327-200020030-00011","article-title":"Low diagnostic yield with second biopsies in suspected giant cell arteritis","volume":"20","author":"Danesh-Meyer","year":"2000","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib40","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/art.34356","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"64","author":"Dasgupta","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib41","first-page":"105","volume":"Vol. 43","author":"de Boysson","year":"2013"},{"key":"10.1016\/j.survophthal.2016.01.001_bib42","first-page":"S34","article-title":"The utility and sensitivity of colour Doppler ultrasound in monitoring changes in giant cell arteritis","volume":"30","author":"De Miguel","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib43","first-page":"373","article-title":"Treatment of giant cell arteritis with cyclophosphamide pulses","volume":"232","author":"de Vita","year":"1992","journal-title":"J Intern Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib44","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCRESAHA.108.185777","article-title":"Toll-like receptors 4 and 5 induce distinct types of vasculitis","volume":"104","author":"Deng","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.survophthal.2016.01.001_bib45","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.109.872903","article-title":"Th17 and Th1 T-cell responses in giant cell arteritis","volume":"121","author":"Deng","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.survophthal.2016.01.001_bib46","doi-asserted-by":"crossref","first-page":"120638","DOI":"10.1155\/2013\/120638","article-title":"Leflunomide as a corticosteroid-sparing agent in giant cell arteritis and polymyalgia rheumatica: a case series","volume":"2013","author":"Diamantopoulos","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.survophthal.2016.01.001_bib47","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ophtha.2009.07.043","article-title":"Increased tissue endothelin-1 and endothelin-B receptor expression in temporal arteries from patients with giant cell arteritis","volume":"117","author":"Dimitrijevic","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2016.01.001_bib48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcjo.2013.12.008","article-title":"Incidence of discordant temporal artery biopsy in the diagnosis of giant cell arteritis","volume":"49","author":"Durling","year":"2014","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib49","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/art.1780371020","article-title":"Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases","volume":"37","author":"Evans","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib50","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0889-857X(05)70153-8","article-title":"Polymyalgia rheumatica and giant cell arteritis","volume":"26","author":"Evans","year":"2000","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.survophthal.2016.01.001_bib51","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-122-7-199504010-00004","article-title":"Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study","volume":"122","author":"Evans","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib52","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V70.5.1572.1572","article-title":"Mechanism of erythrocyte aggregation and sedimentation","volume":"70","author":"Fabry","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.survophthal.2016.01.001_bib53","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2165\/11596480-000000000-00000","article-title":"Might pentoxifylline have a role as adjuvant therapy for patients with giant cell arteritis?","volume":"28","author":"Fern\u00e1ndez-Fern\u00e1ndez","year":"2011","journal-title":"Drugs Aging"},{"key":"10.1016\/j.survophthal.2016.01.001_bib54","first-page":"273","article-title":"Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988","volume":"19","author":"Franzen","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib55","unstructured":"Frohman L: Neuro-Ophthalmology Virtual Education Library (NOVEL). Eccles Library, University Of Utah Health Science Center, American Academy of Ophthalmology\/NorthAmerican Neuro-ophthalmology Collection, 2014"},{"key":"10.1016\/j.survophthal.2016.01.001_bib56","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/rheumatology\/kep011","article-title":"Involvement of the ophthalmic artery in giant cell arteritis visualized by 3T MRI","volume":"48","author":"Geiger","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.survophthal.2016.01.001_bib57","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/rheumatology\/keu241","article-title":"Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study","volume":"54","author":"German\u00f2","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.survophthal.2016.01.001_bib58","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0039-6257(97)00052-0","article-title":"Current concepts in giant cell (temporal) arteritis","volume":"42","author":"Ghanchi","year":"1997","journal-title":"Surv Ophthalmol"},{"issue":"Pt 4","key":"10.1016\/j.survophthal.2016.01.001_bib59","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/eye.1996.101","article-title":"Colour Doppler imaging in giant cell (temporal) arteritis: serial examination and comparison with non-arteritic anterior ischaemic optic neuropathy","volume":"10","author":"Ghanchi","year":"1996","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2016.01.001_bib60","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(09)70134-6","article-title":"Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment","volume":"8","author":"Gilden","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib61","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1212\/WNL.0000000000001409","article-title":"Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis","volume":"84","author":"Gilden","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.survophthal.2016.01.001_bib62","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10067-009-1333-6","article-title":"Mycophenolate mofetil in Takayasu\u2019s arteritis","volume":"29","author":"Goel","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib63","first-page":"289","volume":"Vol. 33","author":"Gonzalez-Gay","year":"2004"},{"key":"10.1016\/j.survophthal.2016.01.001_bib64","first-page":"38","volume":"Vol. 33","author":"Gonz\u00e1lez-Gay","year":"2003"},{"key":"10.1016\/j.survophthal.2016.01.001_bib65","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.md.0000145366.40805.f8","article-title":"Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine"},{"key":"10.1016\/j.survophthal.2016.01.001_bib66","first-page":"179","article-title":"IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis","volume":"20","author":"Gonzalez-Gay","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib67","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.20231","article-title":"Giant cell arteritis without clinically evident vascular involvement in a defined population","volume":"51","author":"Gonzalez-Gay","year":"2004","journal-title":"Arthritis Care Res"},{"issue":"Suppl 2","key":"10.1016\/j.survophthal.2016.01.001_bib68","first-page":"91","article-title":"Cytokines in giant-cell arteritis","volume":"69","author":"Goronzy","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib69","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0167-5273(00)00184-4","article-title":"Giant cell arteritis and Takayasu aortitis: morphologic, pathogenetic and etiologic factors","volume":"75","author":"Gravanis","year":"2000","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib70","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1308\/003588414X13814021679438","article-title":"Facial nerve injury during temporal artery biopsy","volume":"96","author":"Gunawardene","year":"2014","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.survophthal.2016.01.001_bib71","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00005792-198503000-00002","article-title":"Takayasu arteritis: A study of 32 North American patients","volume":"64","author":"Hall","year":"1985","journal-title":"Medicine"},{"key":"10.1016\/j.survophthal.2016.01.001_bib72","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/rheumatology\/kes153","article-title":"Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis","volume":"51","author":"Hauenstein","year":"2012","journal-title":"Rheumatology"},{"issue":"Pt 1","key":"10.1016\/j.survophthal.2016.01.001_bib73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/eye.1990.4","article-title":"Anterior ischaemic optic neuropathy. Differentiation of arteritic from non-arteritic type and its management","volume":"4","author":"Hayreh","year":"1990","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2016.01.001_bib74","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9394(99)80193-7","article-title":"Occult giant cell arteritis: ocular manifestations","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib75","first-page":"322","volume":"Vol. 13","author":"Healey","year":"1984"},{"key":"10.1016\/j.survophthal.2016.01.001_bib76","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/WNO.0b013e31820c4421","article-title":"Statin or nonsteroidal anti-inflammatory drug use is associated with lower erythrocyte sedimentation rate in patients with giant cell arteritis","volume":"31","author":"Hegg","year":"2011","journal-title":"J Neuro-Ophthalmology"},{"key":"10.1016\/j.survophthal.2016.01.001_bib77","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/rheumatology\/41.4.445","article-title":"No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis","volume":"41","author":"Helweg-Larsen","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.survophthal.2016.01.001_bib78","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art1.10161","article-title":"A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis","volume":"47","author":"Hernandez-Rodriguez","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib79","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/rheumatology\/keh058","article-title":"Tissue production of pro-inflammatory cytokines (IL-1\u03b2, TNF\u03b1 and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis","volume":"43","author":"Hernandez-Rodriguez","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.survophthal.2016.01.001_bib80","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.10262","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis","volume":"46","author":"Hoffman","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib81","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-146-9-200705010-00004","article-title":"Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial","volume":"146","author":"Hoffman","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib82","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/ndt\/gfm780","article-title":"Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement","volume":"23","author":"Hu","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.survophthal.2016.01.001_bib83","series-title":"Giant cell arteritis: Clinical aspects","author":"Hunder","year":"2002"},{"issue":"Suppl 2","key":"10.1016\/j.survophthal.2016.01.001_bib84","first-page":"79","article-title":"Epidemiology of giant-cell arteritis","volume":"69","author":"Hunder","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib85","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib86","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJM199711063371910","article-title":"Sonography in giant-cell arteritis","volume":"337","author":"Hunder","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib87","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1007\/s00296-012-2516-z","article-title":"Tocilizumab for giant cell arteritis: an amazing result","volume":"33","author":"I\u015f\u0131k","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.survophthal.2016.01.001_bib88","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.55.7.481","article-title":"Takayasu arteritis: a review","volume":"55","author":"Johnston","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib89","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-134-2-200101160-00010","article-title":"Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial","volume":"134","author":"Jover","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib90","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/art.10867","article-title":"Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: comment on the article by Hoffman et al","volume":"48","author":"Jover","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib91","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/1708538113516322","article-title":"Temporal artery biopsy size does not matter","volume":"22","author":"Kaptanis","year":"2014","journal-title":"Vascular"},{"key":"10.1016\/j.survophthal.2016.01.001_bib92","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1186\/ar2003","article-title":"Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis","volume":"8","author":"Karahaliou","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.survophthal.2016.01.001_bib93","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7326\/0003-4819-142-5-200503010-00011","article-title":"Meta-analysis: Test performance of ultrasonography for giant-cell arteritis","volume":"142","author":"Karassa","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib94","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-510X(03)00167-9","article-title":"Absence of detection of varicella-zoster virus DNA in temporal artery biopsies obtained from patients with giant cell arteritis","volume":"215","author":"Kennedy","year":"2003","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.survophthal.2016.01.001_bib95","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.semarthrit.2011.10.005","article-title":"Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis","volume":"41","author":"Kermani","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib96","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(12)60680-1","article-title":"Polymyalgia rheumatica","volume":"381","author":"Kermani","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2016.01.001_bib97","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-120-11-199406010-00004","article-title":"Takayasu Arteritis","volume":"120","author":"Kerr","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib98","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/RHU.0b013e31822acec6","article-title":"Magnetic Resonance Angiography in Extracranial Giant Cell Arteritis","volume":"17","author":"Koenigkam-Santos","year":"2011","journal-title":"JCR-Journal Clin Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib99","article-title":"Identification of a Burkholderia -Like Strain From Temporal Arteries of Subjects with Giant Cell Arteritis","volume":"64","author":"Koening","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib100","first-page":"S114","article-title":"Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature","volume":"30","author":"K\u00f6tter","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib101","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0002-9440(10)64458-6","article-title":"Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis","volume":"161","author":"Krupa","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib102","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0002-9394(02)02087-1","article-title":"Severe proliferative retinopathy progressing to blindness in a japanese woman with takayasu disease","volume":"135","author":"Kuwahara","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib103","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/ard.48.8.662","article-title":"Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects","volume":"48","author":"Kyle","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2016.01.001_bib104","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/archophthalmol.2012.1204","article-title":"Florid Arteritis Confined to a Single Branch of the Superficial Temporal Artery","volume":"130","author":"Kyung","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10067-010-1598-9","article-title":"18F-FDG PET as a diagnostic procedure in large vessel vasculitis\u2014a controlled, blinded re-examination of routine PET scans","volume":"30","author":"Lehmann","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib106","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.1780330804","article-title":"Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis","volume":"33","author":"Lie","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib107","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/art.21823","article-title":"Clinical Images: Giant cell arteritis revealed by positron emission tomography","volume":"54","author":"Loeb","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib108","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2012-eular.2179","article-title":"Treatment of Refractory Giant Cell Arteritis with Cyclophosphamide. A Retrospective Analysis of 35 Patients from Three Tertiary Care Centers","volume":"71","author":"Loock","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2016.01.001_bib109","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/0961203313519158","article-title":"Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center","volume":"23","author":"Lourdudoss","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.survophthal.2016.01.001_bib110","first-page":"639612","article-title":"Successful treatment of a patient with giant cell vasculitis (horton arteritis) with tocilizumab a humanized anti-interleukin-6 receptor antibody","volume":"2012","author":"Lurati","year":"2012","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib111","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1084\/jem.20030850","article-title":"Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis","volume":"199","author":"Ma-Krupa","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib112","first-page":"221","article-title":"Delayed choroidal perfusion in giant cell arteritis","volume":"11","author":"Mack","year":"1991","journal-title":"J Clin Neuroophthalmol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib113","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/ard.2005.042770","article-title":"Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better?","volume":"65","author":"Mahr","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2016.01.001_bib114","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","article-title":"Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis","volume":"56","author":"Mahr","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib115","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.3899\/jrheum.100353","article-title":"Limited Value of Temporal Artery Ultrasonography Examinations for Diagnosis of Giant Cell Arteritis: Analysis of 77 Subjects","volume":"37","author":"Maldini","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib116","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/ard.2007.082115","article-title":"A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects","volume":"67","author":"Martinez-Taboada","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2016.01.001_bib117","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cyto.2008.09.004","article-title":"Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment","volume":"44","author":"Martinez-Taboada","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.survophthal.2016.01.001_bib118","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.autrev.2014.02.006","article-title":"Effect of antiplatelet\/anticoagulant therapy on severe ischemic complications in patients with giant cell arteritis: A cumulative meta-analysis","volume":"13","author":"Martinez-Taboada","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.survophthal.2016.01.001_bib119","article-title":"Aspirin as adjunctive treatment for giant cell arteritis","author":"Mollan","year":"2013","journal-title":"Cochrane Libr"},{"key":"10.1016\/j.survophthal.2016.01.001_bib120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2567.1997.00246.x","article-title":"Inhibition of human interleukin-12 production by pentoxifylline","volume":"91","author":"Moller","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.survophthal.2016.01.001_bib121","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small and medium vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2016.01.001_bib122","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/j.ophtha.2012.07.020","article-title":"Brow ptosis after temporal artery biopsy: incidence and associations","volume":"119","author":"Murchison","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2016.01.001_bib123","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ajo.2012.03.045","article-title":"Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis","volume":"154","author":"Murchison","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib124","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semarthrit.2006.12.005","article-title":"Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis","volume":"37","author":"Narvaez","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib125","first-page":"1283","article-title":"Analysis of Steroid Related Complications and Mortality in Temporal Arteritis - a 15-Year Survey of 43 Patients","volume":"21","author":"Nesher","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib126","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1128\/JCM.02438-08","article-title":"No Correlation between Giant Cell Arteritis and Chlamydia pneumoniae Infection: Investigation of 189 Patients by Standard and Improved PCR Methods","volume":"47","author":"Njau","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib127","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1309\/8H4L45F5G0G1VKY1","article-title":"\u03a3 ESR An Erythrocyte Sedimentation Rate Adjusted for the Hematocrit and Hemoglobin Concentration","volume":"122","author":"Pawlotsky","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib128","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.survophthal.2011.06.004","article-title":"Blind runner","volume":"57","author":"Pelegrin","year":"2012","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib129","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1080\/08916930903002495","article-title":"Vascular damage in giant cell arteritis","volume":"42","author":"Piggott","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.survophthal.2016.01.001_bib130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCULATIONAHA.110.936203","article-title":"Blocking the NOTCH Pathway Inhibits Vascular Inflammation in Large-Vessel Vasculitis","volume":"123","author":"Piggott","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.survophthal.2016.01.001_bib131","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00041327-200020030-00012","article-title":"Concordance of bilateral temporal artery biopsy in giant cell arteritis","volume":"20","author":"Pless","year":"2000","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib132","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1309\/2996TT2CTLTKN0KT","article-title":"High prevalence of herpes simplex virus DNA in temporal arteritis biopsy specimens","volume":"123","author":"Powers","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib133","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/annrheumdis-2011-200865","article-title":"Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using\u00a0CT\u00a0angiography","volume":"71","author":"Prieto-Gonz\u00e1lez","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2016.01.001_bib134","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.11388","article-title":"Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes","volume":"49","author":"Proven","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib135","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/CIRCULATIONAHA.108.789172","article-title":"Vessel-specific Toll-like receptor profiles in human medium and large arteries","volume":"118","author":"Pryshchep","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.survophthal.2016.01.001_bib136","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jacc.2010.02.063","article-title":"Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography\/computed tomography angiography","volume":"56","author":"Pugliese","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib137","first-page":"562","article-title":"Synovial expression of vasoactive intestinal peptide in polymyalgia rheumatica","volume":"24","author":"Pulsatelli","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib138","first-page":"2014","article-title":"Giant Cell Arteritis: A Systematic Review of the Qualitative and Semiquantitative Methods to Assess Vasculitis with 18F-Fluorodeoxyglucose Positron Emission Tomography","volume":"1-11","author":"Puppo","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.survophthal.2016.01.001_bib139","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/rheumatology\/kes127","article-title":"Role of oral cyclophosphamide in the treatment of giant cell arteritis","volume":"51","author":"Quartuccio","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.survophthal.2016.01.001_bib140","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2005.06.011","article-title":"Giant cell (temporal) arteritis: an overview and update","volume":"50","author":"Rahman","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib141","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-129-5-199809010-00001","article-title":"Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis","volume":"129","author":"Rao","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib142","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1172\/JCI4711","article-title":"Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis","volume":"103","author":"Rittner","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.survophthal.2016.01.001_bib143","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/art.1780360913","article-title":"Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis","volume":"36","author":"Roche","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib144","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/CIRCULATIONAHA.104.520114","article-title":"Metalloproteinase-2 and-9 in giant cell arteritis - Involvement in vascular remodeling","volume":"112","author":"Rodriguez- Pla","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.survophthal.2016.01.001_bib145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"347","author":"Salvarani","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib146","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"372","author":"Salvarani","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2016.01.001_bib147","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780380311","article-title":"Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991","volume":"38","author":"Salvarani","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib148","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/rheumatology\/ker296","article-title":"Tocilizumab: a novel therapy for patients with large-vessel vasculitis","volume":"51","author":"Salvarani","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.survophthal.2016.01.001_bib149","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/rheumatology\/kes387","article-title":"Temporal ultrasonography findings in temporal arteritis: early disappearance of halo sign after only 2 days of steroid treatment","volume":"52","author":"Santoro","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.survophthal.2016.01.001_bib150","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s11606-009-0925-9","article-title":"Delayed diagnosis of biopsy-negative giant cell arteritis presenting as fever of unknown origin","volume":"24","author":"Sch\u00e4fer","year":"2009","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib151","first-page":"822","volume":"Vol. 88","author":"Schmidt","year":"2013"},{"key":"10.1016\/j.survophthal.2016.01.001_bib152","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.berh.2005.01.006","article-title":"What is the best approach to diagnosing large-vessel vasculitis?","volume":"19","author":"Schmidt","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib153","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0140-6736(95)93005-1","article-title":"Colour Doppler sonography to diagnose temporal arteritis","volume":"345","author":"Schmidt","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2016.01.001_bib154","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM199711063371902","article-title":"Color duplex ultrasonography in the diagnosis of temporal arteritis","volume":"337","author":"Schmidt","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib155","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF03325257","article-title":"Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: report of three cases","volume":"24","author":"Sciascia","year":"2012","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.survophthal.2016.01.001_bib156","doi-asserted-by":"crossref","first-page":"w13156","DOI":"10.4414\/smw.2011.13156","article-title":"Rapid induction of remission in large vessel vasculitis by IL-6 blockade","volume":"141","author":"Seitz","year":"2011","journal-title":"Swiss Med Wkly"},{"issue":"Suppl","key":"10.1016\/j.survophthal.2016.01.001_bib157","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0167-5273(96)88783-3","article-title":"Diagnostic criteria for Takayasu arteritis","volume":"54","author":"Sharma","year":"1996","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib158","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9394(14)73525-1","article-title":"Fluorescein angiography in the diagnosis of giant cell arteritis","volume":"115","author":"Siatkowski","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib159","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archopht.1962.00960030012004","article-title":"Occult temporal arteritis","volume":"68","author":"Simmons","year":"1962","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib160","first-page":"S43","article-title":"Imaging findings in extracranial (giant cell) temporal arteritis","volume":"18","author":"Stanson","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib161","first-page":"737","article-title":"Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden","volume":"29","author":"Uddhammar","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib162","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/rheumatology\/37.7.766","article-title":"Cytokines and adhesion molecules in patients with polymyalgia rheumatica","volume":"37","author":"Uddhammar","year":"1998","journal-title":"Rheumatology"},{"key":"10.1016\/j.survophthal.2016.01.001_bib163","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/acr.21750","article-title":"Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica","volume":"64","author":"Unizony","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.survophthal.2016.01.001_bib164","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00006982-199902000-00008","article-title":"Indocyanine green versus fluorescein angiography in the differential diagnosis of arteritic and nonarteritic anterior ischemic optic neuropathy","volume":"19","author":"Valmaggia","year":"1999","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2016.01.001_bib165","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/art.20922","article-title":"Takayasu's arteritis: A study of 104 Italian patients","volume":"53","author":"Vanoli","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib166","first-page":"ker163","article-title":"Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis\u2014a prospective longitudinal study","author":"Visvanathan","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.survophthal.2016.01.001_bib167","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/1529-0131(200007)43:7<1543::AID-ANR19>3.0.CO;2-8","article-title":"Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells","volume":"43","author":"Wagner","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib168","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1172\/JCI117428","article-title":"Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease","volume":"94","author":"Wagner","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.survophthal.2016.01.001_bib169","first-page":"1","article-title":"The pathogenesis of giant cell arteritis","volume":"51","author":"Weyand","year":"2002","journal-title":"Bull Rheum Dis"},{"key":"10.1016\/j.survophthal.2016.01.001_bib170","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/1529-0131(200005)43:5<1041::AID-ANR12>3.0.CO;2-7","article-title":"Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity","volume":"43","author":"Weyand","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib171","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-139-6-200309160-00015","article-title":"Giant-cell arteritis and polymyalgia rheumatica","volume":"139","author":"Weyand","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib172","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMra022694","article-title":"Medium- and large-vessel vasculitis","volume":"349","author":"Weyand","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib173","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-121-7-199410010-00003","article-title":"Tissue Cytokine Patterns in Patients with Polymyalgia-Rheumatica and Giant-Cell Arteritis","volume":"121","author":"Weyand","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2016.01.001_bib174","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/art.10071","article-title":"Therapeutic effects of acetylsalicylic acid in giant cell arteritis","volume":"46","author":"Weyand","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib175","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/WNO.0b013e318268aa9b","article-title":"The immunopathology of giant cell arteritis: diagnostic and therapeutic implications","volume":"32","author":"Weyand","year":"2012","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib176","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780400105","article-title":"Disease patterns and tissue cytokine profiles in giant cell arteritis","volume":"40","author":"Weyand","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.survophthal.2016.01.001_bib177","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1172\/JCI118959","article-title":"Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis","volume":"98","author":"Weyand","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.survophthal.2016.01.001_bib178","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ajo.2011.02.003","article-title":"Facial nerve injury: a complication of superficial temporal artery biopsy","volume":"152","author":"Yoon","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.01.001_bib179","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/bjs.7595","article-title":"Importance of specimen length during temporal artery biopsy","volume":"98","author":"Ypsilantis","year":"2011","journal-title":"Br J Surg"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625715300692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625715300692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:42:17Z","timestamp":1758541337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625715300692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":179,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0039625715300692"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2016.01.001","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New developments in giant cell arteritis","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2016.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}